Advanced Accelerator Applications Reports 29.6% Sales Growth in the First Quarter of 2016
May 31, 2016 07:00 ET
|
Advanced Accelerator Applications
First Quarter Highlights: Sales for the first quarter of 2016 increased 29.6% compared to the first quarter of 2015Purchased 100% of the IDB Group to strengthen AAA’s commercial positioning of...
Advanced Accelerator Applications Appoints Francois Nader, M.D., to Board of Directors
May 26, 2016 07:00 ET
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, May 26, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in Molecular Nuclear...
Advanced Accelerator Applications preparing for Lutathera launch by scaling up production in Ivrea, Italy
May 23, 2016 03:00 ET
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, May 23, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in Molecular Nuclear...
Advanced Accelerator Applications reports 26.8% sales growth in 2015 and continues to show significant clinical progress across both therapeutic and diagnostic platforms
April 29, 2016 07:00 ET
|
Advanced Accelerator Applications
2015 Highlights Reported a year-on-year increase in sales of 26.8% for the full-year and 14% for the fourth quarter of 2015.Completed an IPO and listed on the Nasdaq Global Select Market under the...
Advanced Accelerator Applications to Announce Fourth Quarter and Year End 2015 Financial Results on April 29, 2016
April 22, 2016 07:00 ET
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, April 22, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear...
Advanced Accelerator Applications Provides Lutathera Update
March 23, 2016 07:00 ET
|
Advanced Accelerator Applications
Lutathera Expanded Access Program Now Open In U.S. to Eligible Patients NDA Filing to FDA and EMA Forthcoming SAINT-GENIS-POUILLY, France, March 23, 2016 (GLOBE NEWSWIRE) -- Advanced...
Advanced Accelerator Applications Provides Update on Lutathera and Somakit
February 25, 2016 07:00 ET
|
Advanced Accelerator Applications
Lutathera NETTER-1 Phase 3 Study Update to be Presented at the 13th Annual European Neuroendocrine Tumor Society (ENETS) Conference Notification of PDUFA Date Extension Received for...
Zevacor to Produce SomaKit-TATE Doses for AAA
January 26, 2016 07:00 ET
|
Advanced Accelerator Applications
DULLES, Va., Jan. 26, 2016 (GLOBE NEWSWIRE) -- Zevacor Pharma, Inc. (fka IBA Molecular North America, Inc.), a leader in the manufacture and distribution of radiopharmaceuticals, announced that it...